[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Neurocrine Biosciences, Inc. (NBIX)
Neurocrine Biosciences presents positive three-year data for INGREZZA, and appoints Mike Sibley as SVP, driving positive social engagement. UBS raises Neurocrine Biosciences target to $XXX from $XXX Buy - $NBIX.
About Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc. (NBIX) is a biopharmaceutical company focused on treatments for neurological and endocrine-related disorders.
Neurocrine Biosciences, Inc. uses the ticker $NBIX for trading. Listed in the Stocks and category within the Healthcare sectors.
Insights #
- Neurocrine Biosciences, Inc. (NBIX) sentiment is up XXXXX% from the previous week.
Price: $XXXXXX #
Price 24-Hour Time-Series Raw Data
The stock price is likely to remain positive in the short term due to positive clinical trial data and strong sales, but minor downward pressure from missed EPS estimates may create some volatility. The current price is $139.60, with a XXXX% increase in the last XX hours, and a XXXX% increase in the last X days.
| 24-Hour | 7-Day | 30-Day |
|---|---|---|
| -XXXX% | XXXX% | XXXX% |
1-Year High: $XXXXXX on 2025-01-30
1-Year Low: $XXXXX on 2025-04-08
AltRank: XXXXX #
AltRank 24-Hour Time-Series Raw Data
Neurocrine Biosciences, Inc. (NBIX) is currently AltRank #1,524 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXX +245
1 Month: XXXXX +269
6 Months: XXXXX +954
1 Year: XXXXX +821
1-Year High: XXXXX on 2025-09-25
1-Year Low: XX on 2025-05-06
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX -XX
1 Month: XX -X
6 Months: XX -XX
1 Year: XX -XX
1-Year High: XX on 2025-01-13
1-Year Low: X on 2025-09-24
Engagements: XXXXX #
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXXX
1 Week: XXXXXX -XX%
1 Month: XXXXXX -XX%
6 Months: XXXXXXXXX +50%
1 Year: XXXXXXXXX +11%
1-Year High: XXXXXXX on 2025-05-05
1-Year Low: XXX on 2025-10-15
| Social Network | X | News |
|---|---|---|
| Engagements | XXXXX | X |
Mentions: XXX #
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXXX +426%
1 Year: XXXXXX +389%
1-Year High: XXXXX on 2025-07-03
1-Year Low: XX on 2025-09-14
| Social Network | X | News |
|---|---|---|
| Mentions | XXX | X |
Creators: XX #
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Neurocrine Biosciences, Inc. (NBIX) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XXX
1 Month: XXX -XX%
6 Months: XXXXX +1,107%
1 Year: XXXXXX +978%
1-Year High: XXXXX on 2025-07-03
1-Year Low: X on 2025-10-15
The most influential creators that mention Neurocrine Biosciences, Inc. in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Biobeats99 | X | XXX | XX | XXX |
| @a_a_free | X | XXX | X | XXX |
| @Andre_AGTC | X | XXXXX | X | XXX |
| @SeaHorse_Invest | X | XXX | X | XX |
| @AnitaMc26910087 | X | XXX | X | XX |
| @CrweWorld | X | XXXXX | X | XX |
| @Trader_House04 | X | XX | XX | XX |
| @OzmosiHealth | X | XXXXX | X | XX |
| @Lycanbull | X | XXXXX | X | X |
| @MarcJacksonLA | XX | XXXXX | X | X |
Sentiment: XX% #
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
1 Week: XXX% +40%
1 Month: XX% +25%
6 Months: XX% +9%
1 Year: XX% -XX%
1-Year High: XXX% on 2025-07-20
1-Year Low: XX% on 2025-09-23
Most Supportive Themes
- Strong Ingrezza Sales: (40%) Ingrezza sales are increasing market penetration and revenue.
- Positive Clinical Trial Data: (35%) Positive outcomes from the Crenessity Phase X study boost confidence in Neurocrine's pipeline.
- Affordable Growth Screen: (25%) Mentions in 'Affordable Growth' screens highlight the potential for long-term value.
Most Critical Themes
- Missed EPS Estimates: (5%) Missed EPS estimates may cause short-term volatility.
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XXX | XX% | XXX | XX% | XX | X% |
| News | X | X% | X | X% | X | X% |
| Total | XXX | XX% | XXX | XX% | XX | X% |
Social Dominance: XXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
1 Week: XXXXXX% -XXXXXX%
1 Month: XXXXX% +0.014%
6 Months: XXXXX% -XXXXX%
1 Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-07-03
1-Year Low: XXXXXX% on 2025-09-14
Market Dominance: XXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-04-09
1-Year Low: XXXXX% on 2025-04-14
Market Cap: $XXXXXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXXX
1 Week: $XXXXXXXXXXXXXX +$0.17%
1 Month: $XXXXXXXXXXXXXX -$3.30%
6 Months: $XXXXXXXXXXXXXX +$36%
1 Year: $XXXXXXXXXXXXXX +$16%
1-Year High: $XXXXXXXXXXXXXX on 2025-01-30
1-Year Low: $XXXXXXXXXXXXX on 2025-04-12
Top assets mentioned In the posts about Neurocrine Biosciences, Inc. in the last XX hours
Neurocrine Biosciences, Inc. (NBIX) BioMarin Pharmaceutical, Inc. (BMRN) Cytokinetics Inc. (CYTK) Sage Therapeutics, Inc (SAGE) Karuna Therapeutics, Inc. Common Stock (KRTX) Morgan Stanley (MS) BridgeBio Pharma, Inc. Common Stock (BBIO) United Community Banks, Inc. (UCB) Bristol-Myers Squibb Co (BMY)
Top topics mentioned In the posts about Neurocrine Biosciences, Inc. in the last XX hours
stocks healthcare, investment, telegram, coins defi, $bmrn, stocks, stocks technology, coins dao, $cytk, $sage, $krtx, morgan stanley, stocks industrials, stocks financial services, $bbio, $ucb, $bmy, $mu, $axsm, $acad, $oii, $blue, $xbi, $xene, $lrmr, superrare, stocks consumer cyclical, $nb, $4, $abbv, advanced micro devices, $841k, $1468k, $mtz, $mur, goldman sachs, $ptgx, $mrna, coins solana ecosystem, $myok, $ions, $sotdf, $upwk, regal rexnord corp, $rrx, $mxct, bank of america, $spx, $spy, $qqq, nasdaq, dominance, san diego, approved, $musa, molina healthcare inc, $moh, monaco, $3b, $1b, $mdgl, sarepta therapeutics inc, $alxn, stocks real estate, $rytm, $40050o, $arvn, $apls, $bcax, $bhvn, $kura, $klrs, $iqst, acquisition, $10m, $15m, dawn protocol, $amgn, alnylam pharmaceuticals inc, $alny, coins layer 1, $krys, stocks consumer defensive, $mdlz, $69, $mnst, $lenz, $isrg, $isul, $gd, $cien, $form, $fun, over the, $abcl, $glue, $caba, $autl, $fate, $sdgr
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Thanks for the tag Quick check on those stocks as of Oct XX 2025: $NBIX (Neurocrine Biosciences): Closed at XXXXXX (up 0.53%) analyst avg target XXXXXX. $NCSM (NCS Multistage): Recent prices 41-44 Q3 earnings Oct XX. $OII (Oceaneering): Closed at XXXXX (up 1.85%) avg target XXXXX. DYOR and consider market risks 👌"
X Link @grok 2025-10-14T11:24Z 6.4M followers, XX engagements
"Just the best of the best @grok 👌 $NBIX $NCSM $OII Like 😎 🙏 #tradingstrategy #StocksToBuy #daytrading #UnusualActivity #StockMarket #Stocks #marketupdates #investing #wallstreet #StocksToWatch #ToTheMoon #news #bottomfishing #options #ChatGPT"
X Link @JimyTuits 2025-10-14T11:23Z XXX followers, X engagements
"$BMRN $GMAB $BCRX $JAZZ: I like what they did this year so far. It should be the case for $NBIX $MDGL $EXEL .etc to follow with such deals. Thanks"
X Link @a_a_free 2025-10-14T11:11Z XXX followers, XXX engagements
"WB $DNLI Tivi Priority Review PDUFA Extended Due to Clinical Pharmacology Request Full report in Telegram (in bio)👆 $BLUE $ARWR $VRTX $BMRN $SRPT $IONS $ALNY $EDIT $CRSP $NTLA $BEAM $RGNX $QURE $ABEO $PGEN $FATE $SGMO $ADVM $VERV $PRAX $GLPG $NBIX $ACAD $RARE $VKTX $MOR $ZLAB"
X Link @Biobeats99 2025-10-13T23:18Z XXX followers, XXX engagements